Post-Pandemic Genomic Diversity and Lineage Turnover of Influenza Viruses in Mexico During 2022-2023.

Publication date: May 27, 2026

Seasonal influenza circulation was profoundly disrupted during the COVID-19 pandemic, resulting in an unprecedented global decline in viral activity and genetic diversity. As non-pharmaceutical interventions gradually relaxed, influenza viruses re-emerged in multiple regions in 2022; however, genomic data from Latin America remain limited, particularly for the first post-pandemic season. In this study, we analyzed the epidemiological, genomic, and evolutionary patterns of influenza A and B viruses circulating in Mexico between June 2018 and June 2023, with a specific focus on the first post-pandemic season (June 2022-June 2023). More than 90% of the influenza virus genomes available from Mexico for this post-pandemic period were generated in this study, while data from earlier seasons were used for contextualization. Following a near-complete absence of influenza circulation during 2020-2021, viral activity re-emerged in late 2021 and intensified during 2022-2023. Post-pandemic circulation in Mexico was dominated by influenza A(H3N2), with a lower contribution from A(H1N1)pdm09 and a delayed re-emergence of B/Victoria; B/Yamagata was not detected. Genomic analyses revealed rapid lineage turnover after the pandemic, characterized by the predominance of post-pandemic clades and reduced genetic diversity compared with pre-pandemic seasons. Phylogenetic analyses indicated multiple introductions and strong regional connectivity across North and South America.

Open Access PDF

Concepts Keywords
Genetic Evolution, Molecular
Influenza Genetic Variation
June Genome, Viral
Mexico genomic surveillance
Genomics
Humans
influenza
Influenza A virus
Influenza B virus
Influenza, Human
Mexico
Mexico
Pandemics
Phylogeny
Seasons
virus evolution

Semantics

Type Source Name
disease MESH Influenza
disease MESH COVID-19 pandemic
pathway KEGG Influenza A
drug DRUGBANK Coenzyme M
disease MESH ext
disease MESH infections
disease MESH strain
disease MESH Emerging Communicable Diseases
disease MESH included
drug DRUGBANK Ademetionine
drug DRUGBANK Aspartame
disease MESH NS1
disease MESH NS2
disease MESH star
disease MESH recurrence
drug DRUGBANK Trestolone
disease MESH Dis
disease MESH Lam
drug DRUGBANK Alpha-1-proteinase inhibitor
drug DRUGBANK (S)-Des-Me-Ampa
drug DRUGBANK Carboxyamidotriazole
disease MESH injury
drug DRUGBANK Influenza A virus
drug DRUGBANK Influenza B virus

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *